Personalising care in operable pancreas cancer. GAP-T: a study of imaging and molecular biomarkers to guide treatment of patients receiving preoperative chemotherapy followed by surgery. [ 2012 - 2015 ]

Research Grant

Researchers: Prof Andrew Barbour (Principal investigator) ,  Dr David Chang ,  Dr Ronald Mead ,  Dr Sonia Yip ,  Mr Chris Brown
View all 8 related researchers

Brief description We are studying ways to improve how we treat patients with pancreatic cancer. We will use a novel imaging tool, the PET scanner, to show where active cancer is and how quickly and how well a new drug combination (gemcitabine and nab-paclitaxel) is affecting the cancer. We will also study if measuring the expression of specific proteins (SPARC and hENT1) in the cancer affects the outcome and will allow us to determine ahead of time which patients will benefit most from the drugs.

Funding Amount $AUD 405,345.57

Funding Scheme Project Grants

Notes Standard Project Grant